CD163 and neoplasm: When they shift towards the CD163 + 204 + M2-TAM phenotype through the activation of the signal transducer activator (STAT3) pathway caused by an immunosuppressive cytokine loop, they promote immunosuppression, drug resistance, tumor progression, and metastasis [11,12].